Table 2.
Distribution of molecular variables analysed in whole population
| Characteristic | TOT = 155 |
|---|---|
| N (%) | |
| CDX2 | |
| Low | 47 (32.6%) |
| Intermediate | 50 (34.8%) |
| High | 47 (32.6%) |
| NEa | 11 |
| CK7 | |
| Low | 81 (87.1%) |
| High | 12 (12.9%) |
| NE | 9 |
| Not tested | 53 |
| CK20 | |
| Low | 11 (11.8%) |
| High | 82 (88.2%) |
| NEa | 9 |
| Not tested | 53 |
| CMS | |
| 1 | 44 (39.7%) |
| 2–3 | 47 (42.3%) |
| 4 | 20 (18.0%) |
| NEa | 44 |
| TILs | |
| Low | 61 (39.6%) |
| High | 93 (60.4%) |
| NEa | 1 |
| Barras et al. subtypes | |
| BM1 | 51 (49%) |
| BM2 | 53 (51%) |
| NEa | 51 |
| Clinical prognostic scoreb | |
| Low | 69 (44.8%) |
| Intermediate | 59 (38.3%) |
| High | 26 (16.9%) |
| NEa | 1 |
aNot evaluable
bSimplified version